Genocea Biosciences Inc (GNCA) Return on Investment ROI from the first quarter of 2022 to first quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genocea Biosciences Inc   (NASDAQ: GNCA)


Genocea Biosciences Inc's ROI from its first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Genocea Biosciences Inc's ROI in the first quarter of 2022?
Genocea Biosciences Inc recorded a cumulative net loss of $-37 million during 12 months ending in the first quarter of 2022, resulting in a negative return on investment (ROI) of -84.78%.

Within the Healthcare sector 932 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2022 quarter, so far to 5177, from total ROI ranking in the fourth quarter of 2021 at 5206.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Investment Change TTM -29.07 % 10.62 % 45.19 % 115.09 % 39.75 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 21 42 50 63 73
Return On Investment (TTM) -84.78 % -58.44 % -53.95 % -49.27 % -69.27 %
GNCA's Overall Ranking # 5177 # 5206 # 4249 # 4299 # 4328
Seq. Investment Change TTM -22.78 % -12.2 % -11.06 % 17.61 % 20.44 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -37 -33 -35 -36 -43

GNCA Company Profile >> Back to GNCA Roi Comparisons >> See Annual GNCA Return On Investment



Return On Investment GNCA's Ranking
Within: No.
Industry # 146
Sector # 933
Overall # 5177

Return On Investment Statistics
High Average Low
-35.81 %
-88.73 %
-250.74 %
(Jun 30 2021)   (Dec 31 2017)







Financial Statements
Genocea Biosciences Inc's I. Quarter Investments $ 21 Millions GNCA's Balance sheet
Genocea Biosciences Inc's I. Quarter Income $ -16 Millions Quarterly GNCA's Income Statement
GNCA's Income by Division See GNCA's Income by Division


GNCA Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 37 73 46 17 2
Y / Y Investment Growth -49.27 % 58.64 % 173.96 % 889.53 % -97.13 %
Net Income in Millions -33 -44 -39 -28 -57
Y / Y Net Income Growth - - - - -
Annual Return On Investment -89.04 % -59.48 % -84.07 % -164.46 % -3318.31 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GNCA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GNCA's Competitors
Subscribers only: Roi for Genocea Biosciences Inc's Suppliers
Subscribers only: Return On Investment for GNCA's Customers

Other Ratios
GNCA's Roa GNCA's Inventory Turnover Ratio GNCA's Growth Rates GNCA's Dividend Statistics
GNCA's Profitability Ratios GNCA's Asset Turnover Ratio GNCA's Dividend Growth
GNCA's Roe GNCA's Valuation Ratios GNCA's Financial Strength Ratios GNCA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.